Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future?

World J Methodol. 2023 Sep 20;13(4):194-209. doi: 10.5662/wjm.v13.i4.194.


Antonietta Gerarda Gravina 1Raffaele Pellegrino 2Tommaso Durante 3Giovanna Palladino 2Rossella D'Onofrio 2Simone Mammone 2Giusi Arboretto 2Salvatore Auletta 2Giuseppe Imperio 2Andrea Ventura 2Mario Romeo 2Alessandro Federico 2


Author information

1Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples 80138, Italy. antoniettagerarda.gravina@unicampania.it.

2Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples 80138, Italy.

3Mental Health Department, "S. Pio" Hospital, Benevento 82100, Italy.


Inflammatory bowel disease (IBD) is a chronic digestive disease that requires continuous monitoring by healthcare professionals to determine the appropriate therapy and monitor short-term and long-term complications. The progressive development of information technology has enabled healthcare personnel to deliver care services to patients remotely. Therefore, various applications of telemedicine in IBD management have evolved, including telemonitoring, teleconsulting, teleducation, telenursing, telenutrition, and telepathology. While evidence has been provided for some telemedicine applications, targeted studies are still required. This review summarises the major studies that have evaluated telemedicine and its application in the management of IBD.

© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.